Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 71 (3), 281-285
- https://doi.org/10.1016/j.radonc.2004.02.010
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Comments on inadequacy of iridium implant as sole radiation treatment for operable breast cancer, Fentiman et al., Eur J Cancer 1996, 32A, pp. 608–611European Journal Of Cancer, 1997
- Loco-regional recurrence following mastectomy for early breast carcinoma: efficacy of radiotherapy at the time of recurrenceEuropean Journal of Surgical Oncology, 1997
- Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an UpdateJNCI Journal of the National Cancer Institute, 1996
- Inadequacy of iridium implant as sole radiation treatment for operable breast cancerEuropean Journal Of Cancer, 1996
- Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot studyEuropean Journal of Cancer and Clinical Oncology, 1991
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- ‘Paris’ technique implant dosimetry tables for 0.3 and 0.6 mm diameter192Ir wireThe British Journal of Radiology, 1985